A Multi Center, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 2b Clinical Trial to Evaluate the Efficacy and Safety of N02RS1 in Patients With Acute Bronchitis
Latest Information Update: 01 Apr 2016
At a glance
- Drugs PMK N02RS1 (Primary)
- Indications Bronchitis
- Focus Therapeutic Use
- Sponsors PharmaKing
- 29 Mar 2016 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 24 Dec 2015 New trial record